Showing results (21-30 of 73) with videos related to
Sort By:
Pageof 8
Polish Journal of Pharmacology and Pharmacy|January 1, 1981
Central action of pirenzepineZ Rogóz, G Skuza, H SowińskaPolish Journal of Pharmacology and Pharmacy|October 1, 1981
Effects of antihistaminic drugs in tests for antidepressant actionZ Rogóz, G Skuza, H SowińskaJournal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activityJ Maj, G Skuza, Z RogózPolish Journal of Pharmacology|May 1, 1993
Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effectsJ Maj, Z Rogóz, G SkuzaPolish Journal of Pharmacology|January 1, 1997
Neuropsychopharmacological profile of remoxipride in comparison with clozapineG Skuza, Z Rogóz, A WieczorekPolish Journal of Pharmacology|May 5, 1998
EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine systemG Skuza, Z Rogóz, K GołembiowskaPolish Journal of Pharmacology|December 14, 2004
Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in ratsZ Rogóz, G Skuza, A KłlodzińskaPolish Journal of Pharmacology and Pharmacy|May 1, 1992
The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in ratsJ Maj, Z Rogóz, G SkuzaJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 5, 2006
Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in ratsZ Rogóz, G Skuza, B LegutkoEuropean Journal of Pharmacology|July 9, 1982
Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activityJ Maj, Z Rogóz, G SkuzaPageof 8